BackSeaport Therapeutics Common Stock Overview

Seaport Therapeutics Common Stock Current Cash

Seaport Therapeutics Common Stock's current cash is $64M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$64.22M

Peer trimmed avg / median

Loading

Seaport Therapeutics Common Stock Current Cash History

Loading

Seaport Therapeutics Common Stock vs. peers: Current Cash Comparison

Loading

Seaport Therapeutics Common Stock Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Seaport Therapeutics Common Stock (SPTX) FAQ

Seaport Therapeutics Common Stock's current cash stands at $64M as of June 2026. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Open the history chart to see whether Seaport Therapeutics Common Stock's current cash is expanding or contracting. Sustained growth in current cash can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Seaport Therapeutics Common Stock's current cash evolved across reporting periods, while the comparison chart places SPTX next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, current cash is commonly used to spot outliers. Seaport Therapeutics Common Stock's reading of $64M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.